PARIS – A French court has ordered Sanofi to pay more than 400,000 euros ($416,440) in damages to a family whose child suffered from a form of autism caused by its epilepsy drug Valproate, saying the drugmaker failed to inform …
A French court ruled that families of children who suffered side effects from the epilepsy medicine Depakine can join in a class-action lawsuit against drugmaker Sanofi. The company should have warned of the risk of birth defects for pregnant women …
Up to 4,100 children in France suffered major malformations in the womb after their mothers took a treatment against epilepsy and bipolar disorders known as valproate between 1967 and 2016, France’s drug regulator said. Valproate, which has been manufactured in …
More than 10,000 pregnant women in France took Sanofi’s anti-epilepsy drug Depakine between 2007 and 2014 although the risk of fetus malformation was known, according to a study quoted by French satirical weekly Le Canard Enchaine. The weekly reported that …
